164 related articles for article (PubMed ID: 15959806)
21. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
[TBL] [Abstract][Full Text] [Related]
22. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
[TBL] [Abstract][Full Text] [Related]
23. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
[TBL] [Abstract][Full Text] [Related]
24. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
25. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.
Putt W; Palmen J; Nicaud V; Tregouet DA; Tahri-Daizadeh N; Flavell DM; Humphries SE; Talmud PJ;
Hum Mol Genet; 2004 Aug; 13(15):1587-97. PubMed ID: 15175273
[TBL] [Abstract][Full Text] [Related]
26. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
[TBL] [Abstract][Full Text] [Related]
27. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
Aouizerat BE; Allayee H; Cantor RM; Davis RC; Lanning CD; Wen PZ; Dallinga-Thie GM; de Bruin TW; Rotter JI; Lusis AJ
Am J Hum Genet; 1999 Aug; 65(2):397-412. PubMed ID: 10417282
[TBL] [Abstract][Full Text] [Related]
28. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
[TBL] [Abstract][Full Text] [Related]
29. Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.
Kantartzis K; Fritsche A; Machicao F; Stumvoll M; Machann J; Schick F; Häring HU; Stefan N
J Mol Med (Berl); 2007 Jan; 85(1):55-61. PubMed ID: 17016691
[TBL] [Abstract][Full Text] [Related]
30. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
[TBL] [Abstract][Full Text] [Related]
31. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
[TBL] [Abstract][Full Text] [Related]
33. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
[TBL] [Abstract][Full Text] [Related]
34. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
[TBL] [Abstract][Full Text] [Related]
35. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
[TBL] [Abstract][Full Text] [Related]
36. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.
Cullen P; Farren B; Scott J; Farrall M
Arterioscler Thromb; 1994 Aug; 14(8):1233-49. PubMed ID: 8049184
[TBL] [Abstract][Full Text] [Related]
37. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood.
Shamir R; Tershakovec AM; Gallagher PR; Liacouras CA; Hayman LL; Cortner JA
Atherosclerosis; 1996 Mar; 121(1):85-91. PubMed ID: 8678927
[TBL] [Abstract][Full Text] [Related]
38. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
39. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
[TBL] [Abstract][Full Text] [Related]
40. Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia.
Naoumova RP; Bonney SA; Eichenbaum-Voline S; Patel HN; Jones B; Jones EL; Amey J; Colilla S; Neuwirth CK; Allotey R; Seed M; Betteridge DJ; Galton DJ; Cox NJ; Bell GI; Scott J; Shoulders CC
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2070-7. PubMed ID: 14500288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
